Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
暂无分享,去创建一个
Fan Wang | Fan Wang | Yashuang Zhao | Ya-shuang Zhao | Sui Zhu | Xiang-wei Li | Fu-lan Hu | Dan-dan Li | Wen-cui Zhang | Xia Li | Dan-dan Li | Xiang-wei Li | Fu-lan Hu | Wencui Zhang | Sui Zhu | Xia Li
[1] M. Thun,et al. Risk factors for self-reported colon polyps , 1998, Journal of General Internal Medicine.
[2] L. G. García Rodríguez,et al. Risk of breast cancer among users of aspirin and other anti-inflammatory drugs , 2004, British Journal of Cancer.
[3] M. Cotterchio,et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk , 2006, Breast Cancer Research.
[5] M. Thun,et al. Aspirin use and risk of fatal cancer. , 1993, Cancer research.
[6] A. Folsom,et al. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[7] M. Thun,et al. Association of Polymorphisms in the Paraoxonase 1 Gene with Breast Cancer Incidence in the CPS-II Nutrition Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.
[8] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[9] U. Vogel,et al. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. , 2006, Carcinogenesis.
[10] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[11] F. Robertson,et al. Cyclooxygenase-2 gene expression in human breast cancer. , 1997, International journal of oncology.
[12] N. Petrelli,et al. Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.
[13] J. Watson,et al. Prostaglandins, steroids and human mammary cancer. , 1985, European journal of cancer & clinical oncology.
[14] H. Ury,et al. Initial screening for carcinogenicity of commonly used drugs. , 1980, Journal of the National Cancer Institute.
[15] W. Farrar,et al. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. , 1999, Oncology reports.
[16] Harukazu Tsuruta,et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data , 2006, BMC medical research methodology.
[17] P. Loehrer. Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer , 2007 .
[18] R. Lancashire,et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.
[19] I. Sartori. Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals. , 1996 .
[20] J. Barkin. The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force , 2008 .
[21] Randall Harris,et al. Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. , 2007, Sub-cellular biochemistry.
[22] J. Ghosn,et al. Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer , 2005, BMC Cancer.
[23] Randall Harris,et al. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors , 2006, BMC Cancer.
[24] L F Watson,et al. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.
[25] U. Vogel,et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[26] K. Helzlsouer,et al. Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease , 2006, Cancer.
[27] K. Namboodiri,et al. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. , 1995, Preventive medicine.
[28] A. McTiernan,et al. NSAID use and breast cancer risk in the VITAL cohort , 2008, Breast Cancer Research and Treatment.
[29] D F Roychowdhury,et al. Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.
[30] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[31] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[32] S. Neuhausen,et al. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] B. Henderson,et al. Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.
[34] A. Folsom,et al. NSAID use and survival after breast cancer diagnosis in post-menopausal women , 2006, Breast Cancer Research and Treatment.
[35] S Duval,et al. Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.
[36] R. Millikan,et al. Cyclooxygenase 2 Polymorphism (Val511Ala), Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer in African American Women , 2005, Cancer Epidemiology Biomarkers & Prevention.
[37] A. Neugut,et al. MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York , 2005, Cancer Causes & Control.
[38] L. Rosenberg. Nonsteroidal anti-inflammatory drugs and cancer. , 1995, Preventive medicine.
[39] Sowmya R. Rao,et al. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. , 1999, Preventive medicine.
[40] M. Thun,et al. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] D. Mirick,et al. Medication use and the risk of breast cancer , 2007, European Journal of Epidemiology.
[42] H. Sano,et al. Expression of Cyclooxygenase-1 and -2 in Human Breast Cancer , 2003, Surgery Today.
[43] M. Cotterchio,et al. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. , 2007, American journal of epidemiology.
[44] G. Anderson,et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. , 2003, Cancer research.
[45] K. Moysich,et al. Association of Regular Aspirin Use and Breast Cancer Risk , 2005, Oncology.
[46] K. Helzlsouer,et al. Nonsteroidal anti‐inflammatory drugs and the risk of developing breast cancer in a population‐based prospective cohort study in Washington County, MD , 2007, International journal of cancer.
[47] P. Schlattmann,et al. Aspirin use and breast cancer risk: a meta‐analysis and meta‐regression of observational studies from 2001 to 2005 , 2008, Pharmacoepidemiology and drug safety.
[48] H. Jick,et al. Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.
[49] A. Neugut,et al. Association between coronary heart disease and cancers of the breast, prostate, and colon. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[50] Stephen D. Persell,et al. Low-Dose Aspirin Does Not Reduce Cancer Incidence in Women Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55. , 2005 .
[51] T. Byers,et al. IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States , 2007, Cancer Epidemiology Biomarkers & Prevention.
[52] N. Feller,et al. Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients , 2004, Journal of Cancer Research and Clinical Oncology.
[53] J. Palmer,et al. Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. , 2005, American journal of epidemiology.
[54] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[55] R. Everson,et al. Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.
[56] J. Manson,et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. , 2005, JAMA.
[57] J. Olsen,et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin , 2003, British Journal of Cancer.
[58] J A Hanley,et al. Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage , 2000 .
[59] H T Sørensen,et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study , 2003, British Journal of Cancer.
[60] G. Colditz,et al. Prospective study of regular aspirin use and the risk of breast cancer. , 1996, Journal of the National Cancer Institute.
[61] M. Thun,et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. , 2007, Journal of the National Cancer Institute.
[62] D. Stram,et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. , 2005, Journal of the National Cancer Institute.
[63] R. Millikan,et al. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast , 2003, Cancer Causes & Control.
[64] S. Khuder,et al. Breast cancer and NSAID use: a meta-analysis , 2001, British Journal of Cancer.
[65] L. Habel,et al. NSAIDs and breast cancer recurrence in a prospective cohort study , 2007, Cancer Causes & Control.
[66] R. López‐Ridaura,et al. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis , 2003, BMC Cancer.
[67] K. Namboodiri,et al. Nonsteroidal antiinflammatory drugs and breast cancer. , 1996, Epidemiology.
[68] M. Pike,et al. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. , 2006, American journal of epidemiology.
[69] J. Manson,et al. Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial , 2008, British Journal of Cancer.